A successful case of nonoperative, organ-preserving management of locally advanced rectal cancer.
A new study confirms that preoperative pelvic radiation, with or without concurrent chemotherapy, is safe and effective in IBD patients with locally advanced rectal cancer.
If you’re looking for the latest insights and leading-edge information on IBD and gastrointestinal endoscopy, you’ll want to attend these upcoming Cleveland Clinic CME events.
Transanal mesorectal total excision (TaTME) for rectal cancer has been so successful that the technique is being expanded to many other complex pelvic surgery patients. Dr. Dana Sands explains.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
How robotic-assisted surgery is helping achieve low recurrence rates, lower anastomotic complication rates and improved outcomes for rectal cancer patients.
What happens when you use the statistical conclusion that laparoscopy is not inferior to laparotomy rather than the more logical conclusion that laparotomy is superior to laparoscopy? Cleveland Clinic Florida Colorectal Chairman Steven Wexner, MD, discusses in our “Viewpoints” series.
Matthew Kalady, MD, comments on a recent study that found that NCCN-recommended rectal cancer treatment has a much lower rate of effectiveness in patients under 50 years old.
Research presented at DDW 2018 concludes that patients who have positive lateral pelvic lymph nodes before and after neo-adjuvant treatment are the ones who may benefit from lateral pelvic lymph node dissection. Dr. Emre Gorgun explains.
While any type of minimally invasive procedure is superior to an open one, new evidence shows robotic and laparoscopic TME have similar outcomes.
A new study presented at ASCRS 2018 is the first to show that radiated CAFs can promote tumor progression in colorectal cancer and how this occurs. Dr. David Liska explains.